ClinicalTrials.Veeva

Menu

The Association Between Molecular Typing of Treponema Pallidum and Treatment Efficacy and Clinical Findings

Chinese Academy of Medical Sciences & Peking Union Medical College logo

Chinese Academy of Medical Sciences & Peking Union Medical College

Status and phase

Unknown
Phase 4

Conditions

Syphilis

Treatments

Drug: Benzathine Penicillin G

Study type

Interventional

Funder types

Other

Identifiers

NCT02871505
PUMCH-2016079

Details and patient eligibility

About

The investigators compare the treatment results and clicical presentations of different Molecular subtyping of Treponema pallidum

Enrollment

150 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

  1. Persons with confirmed early symptomatic syphilis (primary or secondary) or high-titer latent syphilis

Exclusion Criteria:

  1. Pregnant woman
  2. Known allergy to penicillin
  3. RPR titers were found to be 1:8 or less

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

150 participants in 2 patient groups

Molecular subtyping (14d/f) of Treponema pallidum
Experimental group
Description:
Benzathine Penicillin G treatment
Treatment:
Drug: Benzathine Penicillin G
Molecular subtyping (others) of Treponema pallidum
Experimental group
Description:
Benzathine Penicillin G treatment
Treatment:
Drug: Benzathine Penicillin G

Trial contacts and locations

1

Loading...

Central trial contact

Jun Li, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems